Gazprom and the European Commission need further talks to assess the Russian gas giant’s compliance with EU competition law, they said after a meeting on Monday in Brussels.
Gazprom’s deputy chief executive, Alexander Medvedev, met EU antitrust chief Margrethe Vestager to discuss concessions aimed at ending a six-year-long investigation into Gazprom’s alleged anti-competitive practices in the supply of gas to eastern and central Europe.
“We had a very productive discussion today with Commissioner Vestager and her team. We have agreed to hold further talks at technical level in the coming weeks,” Medvedev said in a statement.
To meet EU requests, Gazprom offered to let clients renegotiate decades-long, oil-indexed contracts, with prices linked to benchmarks such as European gas market hubs and border prices, including in Germany.
The concessions made by Gazprom are now being tested to assess their impact in the market. Some rivals, such as state-run Polish oil and gas company PGNiG, are calling for the offer to be turned down and Gazprom to be fined.
“Further contacts with Gazprom are required to address the results of the market test and ensure the Commission’s objectives are met,” a spokesman for Vestager said after the meeting.
Full Content: Oil Price
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas